US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist
  • 4.900
  • -0.010-0.20%
Trading Dec 19 09:33 ET
272.41MMarket Cap-2.65P/E (TTM)

About Foghorn Therapeutics Company

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.

Company Profile

SymbolFHTX
Company NameFoghorn Therapeutics
Listing DateOct 23, 2020
Issue Price16.00
Founded2015
CEOMr. Adrian Gottschalk
MarketNASDAQ
Employees116
Fiscal Year Ends12-31
Address500 Technology Square,Suite 700
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-586-3100
Websitehttp://www.foghorntx.com

Company Executives

  • Name
  • Position
  • Salary
  • Adrian Gottschalk
  • Chief Executive Officer and Director
  • 2.50M
  • Fanny Cavalie
  • Chief Strategy and Business Operations Officer
  • --
  • Dr. Steven F. Bellon, PhD
  • Chief Scientific Officer
  • 1.19M
  • Kristian F. Humer
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Michael J. LaCascia
  • Chief Legal Officer
  • --
  • Carlos Costa
  • Chief People Officer
  • --
  • Dr. Alfonso Quintas-Cardama
  • Chief Medical Officer
  • 1.84M
  • Dr. Douglas G. Cole, M.D.
  • Chairman of the Board
  • 184.57K
  • Dr. Balkrishan Gill, PhD
  • Independent Director
  • 159.07K
  • Dr. Adam M. Koppel, M.D.,PhD
  • Independent Director
  • 153.07K
  • B. Lynne Parshall, Esq.,J.D.
  • Independent Director
  • 157.65K
  • Dr. Thomas J. Lynch
  • Independent Director
  • 145.57K
  • Ian F. Smith
  • Independent Director
  • 141.57K
  • Dr. Scott Biller, PhD
  • Independent Director
  • 145.57K
  • Dr. Michael Mendelsohn, M.D.
  • Independent Director
  • 154.57K
  • Stephen J. DiPalma
  • Treasurer
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data